1. Home
  2. xl 650613

US20190247420A1 - Compounds and methods for reducing atxn3 expression - Google Patents

$ 18.99

4.8 (465) In stock

Patent application publication

US10881730B2 - Immunomodulatory therapeutic MRNA compositions encoding activating oncogene mutation peptides - Google Patents

WO2017143291A1 - METHODS AND COMPOUNDS FOR RESTORING MUTANT p53 FUNCTION - Google Patents

US20100204312A1 - Methods and compositions for treating cancer - Google Patents

High throughput compound screening in neuronal cells identifies statins as activators of ataxin 3 expression

Druggable genome screen identifies new regulators of the abundance and toxicity of ATXN3, the Spinocerebellar Ataxia type 3 disease protein - ScienceDirect

High throughput compound screening in neuronal cells identifies statins as activators of ataxin 3 expression

Physiological and pathophysiological characteristics of ataxin-3 isoforms - ScienceDirect

Physiological and pathophysiological characteristics of ataxin-3 isoforms - ScienceDirect

High throughput compound screening in neuronal cells identifies statins as activators of ataxin 3 expression